Protected From a Form of Cell Death, Women are More Resilient to Kidney Disease
A study led by Duke Health researchers provides some insights: Females, it turns out, have an advantage at the molecular level that protects them from a form of cell death that occurs in injured kidneys. This protection could be exploited as a potential therapeutic.
Determining Genetic Causes for Sudden Cardiac Death
People commonly associate heart attacks with clogged arteries, fatty diets, high cholesterol, and plaque buildup in the heart. And while all those things can cause sudden cardiac death, they are not the only culprit; gene mutations can also be to blame.
Mysterious Outbreak of Bone-eating TB Resembled an Ancestral Form
Driving force behind strange NC outbreak solved by a Duke collaboration
Study Finds Patient’s Race Affects Ovarian Cancer Care
Non-Hispanic Black patients are less likely to receive guideline-appropriate treatment for ovarian cancer than non-Hispanic White patients, significantly affecting their treatment quality and survival chances.
The Kids Are Not Alright: NC-PAL expands access to pediatric mental health services
NC-PAL is a free provider-to-provider consultation line and education program available to all clinicians across the state for questions about behavioral health or psychiatric medication management for their pediatric and perinatal patients. Nicole Heilbron and Gary Maslow are leads of the program, part of the statewide effort to address the youth mental health crisis.
Modeling a Pandemic in a Tube
New tool provides a framework to identify human genetic determinants of infectious disease outcomes.
Closing the Gap in Veteran Suicide Research
Operation Deep Dive is a partnership between Duke School of Medicine and American Warrior Project to examine the factors and causes of suicide among veterans and former service members.
Chest Pain Patients Benefit from Precision Diagnostic Testing Approach
A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.
Two Alzheimer’s Drugs Tested Head-to-Head in First-Ever Virtual Clinical Trial
An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease.
Mechanism Identified for Drug Resistance in Glioblastoma Brain Tumors
Duke Health researchers have identified a unique process within the environment of deadly brain tumors that drives resistance to immune-boosting therapies and could be targeted to promote the effects of those drugs.